OncoSil Medical Limited (ASX:OSL)

OncoSil Medical Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 28, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	28	17	13	24	40	42
Market Cap Growth	-46.70%	28.03%	-43.79%	-40.20%	-6.18%	-55.65%
Enterprise Value	23	9	9	18	33	24
Last Close Price	1.50	1.20	1.60	4.53	12.28	16.07
PS Ratio	18.39	11.12	8.51	16.16	37.28	32.55
PB Ratio	9.10	5.50	2.81	2.40	3.55	3.61
P/TBV Ratio	9.10	5.50	2.81	2.40	3.55	3.61
EV/Sales Ratio	15.11	5.65	5.46	12.39	31.40	18.78
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.03	0.04
Asset Turnover	0.22	0.22	0.17	0.12	0.08	0.07
Quick Ratio	1.57	1.57	3.06	6.81	6.89	6.29
Current Ratio	1.67	1.67	3.26	7.16	7.21	6.39
Return on Equity (ROE)	-385.20%	-385.20%	-163.01%	-107.80%	-93.85%	-62.11%
Return on Assets (ROA)	-136.02%	-136.02%	-82.34%	-57.73%	-48.58%	-34.49%
Return on Capital (ROIC)	-236.34%	-236.34%	-100.82%	-65.85%	-55.91%	-38.54%
Earnings Yield	-53.47%	-88.48%	-89.39%	-47.84%	-27.05%	-24.69%
FCF Yield	-42.77%	-70.77%	-82.69%	-47.97%	-25.52%	-20.99%
Buyback Yield / Dilution	-97.77%	-97.77%	-95.67%	-39.32%	0.89%	-24.68%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.